|
| | Ropivacaine hydrochloride Basic information |
| | Ropivacaine hydrochloride Chemical Properties |
| Melting point | 267-269°C | | alpha | D20 -7.28° (c = 2 in water) | | storage temp. | 2-8°C | | solubility | H2O: soluble5mg/mL, clear | | form | powder | | color | white to off-white | | optical activity | [α]/D -9 to -12, c = 1 in methanol | | InChIKey | VSHFRHVKMYGBJL-CKUXDGONSA-N | | CAS DataBase Reference | 132112-35-7(CAS DataBase Reference) |
| | Ropivacaine hydrochloride Usage And Synthesis |
| Description | (–)-Ropivacaine is a potent and reversible blocker of sodium channels in nerve fibers. In vivo, (–)-ropivacaine induces complete impairment of proprioception, motor function, and nociception in the hindleg of rats when 100 μL of an 8 mM solution is injected percutaneously into the sciatic nerve. (–)-Ropivacaine depresses myocardial contractile force in isolated rat hearts less potently than (±)-ropivacaine, as well as (–)- and (±)-bupivacaine . Formulations containing (–)-ropivacaine have been used as local anesthetics during surgery and childbirth. | | Chemical Properties | White Solid | | Uses | Anesthetic (local). | | Uses | Ropivacaine hydrochloride monohydrate has been used as an analyte in tandem mass spectrometry and as an amide-based local anaesthetic to test its effect on breast cancer cell methylation. | | Definition | ChEBI: The monohydrate form of (S)-ropivacaine hydrochloride. | | General Description | Ropivacaine has lidocaine-related structure with tertiary amine side chains.?It is a pure S(-)enantiomer with a propyl group on the piperidine nitrogen atom. | | Biochem/physiol Actions | Local anaesthetic with less cardiotoxicity than bupivacaine; causes reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the cell membrane of the nerve fibers. |
| | Ropivacaine hydrochloride Preparation Products And Raw materials |
|
